Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIMOS 3D: Ibandronate Bone Structure Study
NCT00271713Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postmenopausal osteoporosis comparing Ibandronate with Placebo (2 arms). Primary endpoint: Bone Volume/Total Volume and Trabecular Separation at 12 months. Started Mar 2006; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00271713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271713.